Summary
Dendritic cells are the sentinels of the immune system, which instruct the differentiation of helper T cells along various lineages and thus, critically determine the type, intensity, and duration of the immune response. The last decade witnessed the clinical implementation of the dendritic cell vaccination against cancer, which represents a paradigm of translational research and is a contribution to personalized medicine. Dendritic cell-based immunotherapy has been demonstrated to be feasible and well-tolerated and, moreover, to induce immune and clinical responses. The experience gained with dendritic cell therapy of cancer may form the basis for the extension of this therapy to the treatment of allergy and autoimmune disease including transplant rejection.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Steinman, R. M. 1991. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9:271.
Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245.
Reiner, S. L. 2007. Development in motion: helper T cells at work. Cell 129:33.
Rutella, S., S. Danese, and G. Leone. 2006. Tolerogenic dendritic cells: cytokine modulation comes of age. Blood 108:1435.
Rieser, C., G. Bock, H. Klocker, G. Bartsch, and M. Thurnher. 1997. Prostaglandin E2 and tumor necrosis factor alpha cooperate to activate human dendritic cells: synergistic activation of interleukin 12 production. J Exp Med 186:1603.
Banchereau, J., and A. K. Palucka. 2005. Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol 5:296.
Figdor, C. G., I. J. de Vries, W. J. Lesterhuis, and C. J. Melief. 2004. Dendritic cell immuno-therapy: mapping the way. Nat Med 10:475.
Schuler, G., B. Schuler-Thurner, and R. M. Steinman. 2003. The use of dendritic cells in cancer immunotherapy. Curr Opin Immunol 15:138.
Burnet, F. M. 1970. The concept of immunological surveillance. Prog Exp Tumor Res 13:1
Dunn, G. P., L. J. Old, and R. D. Schreiber. 2004. The immunobiology of cancer immunosur-veillance and immunoediting. Immunity 21:137.
Thurnher, M., C. Radmayr, R. Ramoner, S. Ebner, G. Bock, H. Klocker, N. Romani, and G. Bartsch. 1996. Human renal-cell carcinoma tissue contains dendritic cells. Int J Cancer 68:1.
Radmayr, C., G. Bock, A. Hobisch, H. Klocker, G. Bartsch, and M. Thurnher. 1995. Dendritic antigen-presenting cells from the peripheral blood of renal-cell-carcinoma patients. Int J Cancer 63:627.
Thurnher, M., C. Radmayr, A. Hobisch, G. Bock, N. Romani, G. Bartsch, and H. Klocker. 1995. Tumor-infiltrating T lymphocytes from renal-cell carcinoma express B7-1 (CD80): T-cell expansion by T-T cell co-stimulation. Int J Cancer 62:559.
Galon, J., A. Costes, F. Sanchez-Cabo, A. Kirilovsky, B. Mlecnik, C. Lagorce-Pages, M. Tosolini, M. Camus, A. Berger, P. Wind, F. Zinzindohoue, P. Bruneval, P. H. Cugnenc, Z. Trajanoski, W. H. Fridman, and F. Pages. 2006. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313:1960.
Thompson, R. H., S. M. Kuntz, B. C. Leibovich, H. Dong, C. M. Lohse, W. S. Webster, S. Sengupta, I. Frank, A. S. Parker, H. Zincke, M. L. Blute, T. J. Sebo, J. C. Cheville, and E. D. Kwon. 2006. Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up. Cancer Res 66:3381.
Romani, N., S. Gruner, D. Brang, E. Kampgen, A. Lenz, B. Trockenbacher, G. Konwalinka, P. O. Fritsch, R. M. Steinman, and G. Schuler. 1994. Proliferating dendritic cell progenitors in human blood. J Exp Med 180:83.
Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179:1109.
Caux, C., C. Dezutter-Dambuyant, D. Schmitt, and J. Banchereau. 1992. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 360:258.
Banchereau, J., A. K. Palucka, M. Dhodapkar, S. Burkeholder, N. Taquet, A. Rolland, S. Taquet, S. Coquery, K. M. Wittkowski, N. Bhardwaj, L. Pineiro, R. Steinman, and J. Fay. 2001. Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine. Cancer Res 61:6451.
Brugarolas, J. 2007. Renal-cell carcinoma--molecular pathways and therapies. N Engl J Med 356:185.
Holtl, L., C. Rieser, C. Papesh, R. Ramoner, G. Bartsch, and M. Thurnher. 1998. CD83+ blood dendritic cells as a vaccine for immunotherapy of metastatic renal-cell cancer. Lancet 352:1358.
Holtl, L., C. Zelle-Rieser, H. Gander, C. Papesh, R. Ramoner, G. Bartsch, H. Rogatsch, A. L. Barsoum, J. H. Coggin, Jr., and M. Thurnher. 2002. Immunotherapy of metastatic renal cell carcinoma with tumor lysate-pulsed autologous dendritic cells. Clin Cancer Res 8:3369.
Holtl, L., R. Ramoner, C. Zelle-Rieser, H. Gander, T. Putz, C. Papesh, W. Nussbaumer, C. Falkensammer, G. Bartsch, and M. Thurnher. 2004. Allogeneic dendritic cell vaccination against metastatic renal cell carcinoma with or without cyclophosphamide. Cancer Immunol Immunother.
Jonuleit, H., U. Kuhn, G. Muller, K. Steinbrink, L. Paragnik, E. Schmitt, J. Knop, and A. H. Enk. 1997. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol 27:3135.
Rieser, C., R. Ramoner, L. Holtl, H. Rogatsch, C. Papesh, A. Stenzl, G. Bartsch, and M. Thurnher. 1999. Mature dendritic cells induce T-helper type-1-dominant immune responses in patients with metastatic renal cell carcinoma. Urol Int 63:151.
Zelle-Rieser, C., A. L. Barsoum, F. Sallusto, R. Ramoner, J. W. Rohrer, L. Holtl, G. Bartsch, J. J. Coggin, and M. Thurnher. 2001. Expression and immunogenicity of oncofetal antigen-immature laminin receptor in human renal cell carcinoma. J Urol 165:1705.
Cohen, H. T., and F. J. McGovern. 2005. Renal-cell carcinoma. N Engl J Med 353:2477.
Kleinrath, T., C. Gassner, P. Lackner, M. Thurnher, and R. Ramoner. 2007. Interleukin-4 promoter polymorphisms: a genetic prognostic factor for survival in metastatic renal cell carcinoma. J Clin Oncol 25:845.
Lanzavecchia, A., and F. Sallusto. 2005. Understanding the generation and function of memory T cell subsets. Curr Opin Immunol 17:326.
Kay, A. B. 2001. Allergy and allergic diseases. First of two parts. N Engl J Med 344:30.
Ziegler, S. F., and Y. J. Liu. 2006. Thymic stromal lymphopoietin in normal and pathogenic T cell development and function. Nat Immunol 7:709.
Soumelis, V., P. A. Reche, H. Kanzler, W. Yuan, G. Edward, B. Homey, M. Gilliet, S. Ho, S. Antonenko, A. Lauerma, K. Smith, D. Gorman, S. Zurawski, J. Abrams, S. Menon, T. McClanahan, R. de Waal-Malefyt Rd, F. Bazan, R. A. Kastelein, and Y. J. Liu. 2002. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 3:673.
Zhou, B., M. R. Comeau, T. De Smedt, H. D. Liggitt, M. E. Dahl, D. B. Lewis, D. Gyarmati, T. Aye, D. J. Campbell, and S. F. Ziegler. 2005. Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice. Nat Immunol 6:1047.
Ebner, S., V. A. Nguyen, M. Forstner, Y. H. Wang, D. Wolfram, Y. J. Liu, and N. Romani. 2007. Thymic stromal lymphopoietin converts human epidermal Langerhans cells into antigen-presenting cells that induce proallergic T cells. J Allergy Clin Immunol 119:982.
Mazzoni, A., H. A. Young, J. H. Spitzer, A. Visintin, and D. M. Segal. 2001. Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization. J Clin Invest 108:1865.
Thurnher, M. 2007. Lipids in dendritic cell biology: messengers, effectors, and antigens. J Leukoc Biol 81:154.
Liu, M. C., E. R. Bleecker, L. M. Lichtenstein, A. Kagey-Sobotka, Y. Niv, T. L. McLemore, S. Permutt, D. Proud, and W. C. Hubbard. 1990. Evidence for elevated levels of histamine, prostaglandin D2, and other bronchoconstricting prostaglandins in the airways of subjects with mild asthma. Am Rev Respir Dis 142:126.
Gosset, P., F. Bureau, V. Angeli, M. Pichavant, C. Faveeuw, A. B. Tonnel, and F. Trottein. 2003. Prostaglandin D2 affects the maturation of human monocyte-derived dendritic cells: consequence on the polarization of naive Th cells. J Immunol 170:4943.
Hammad, H., M. Kool, T. Soullie, S. Narumiya, F. Trottein, H. C. Hoogsteden, and B. N. Lambrecht. 2007. Activation of the D prostanoid 1 receptor suppresses asthma by modulation of lung dendritic cell function and induction of regulatory T cells. J Exp Med 204:357.
Watanabe, N., Y. H. Wang, H. K. Lee, T. Ito, W. Cao, and Y. J. Liu. 2005. Hassall's corpuscles instruct dendritic cells to induce CD4 + CD25+ regulatory T cells in human thymus. Nature 436:1181.
Steinman, R. M., and I. Mellman. 2004. Immunotherapy: bewitched, bothered, and bewildered no more. Science 305:197.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer
About this chapter
Cite this chapter
Thurnher, M. (2010). Dendritic Cell Vaccines. In: Pawankar, R., Holgate, S.T., Rosenwasser, L.J. (eds) Allergy Frontiers: Future Perspectives. Allergy Frontiers, vol 6. Springer, Tokyo. https://doi.org/10.1007/978-4-431-99365-0_17
Download citation
DOI: https://doi.org/10.1007/978-4-431-99365-0_17
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-99364-3
Online ISBN: 978-4-431-99365-0
eBook Packages: MedicineMedicine (R0)